{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:40:02Z","timestamp":1792885202385,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RA 689\/12-1"],"award-info":[{"award-number":["RA 689\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422179811"],"award-info":[{"award-number":["422179811"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RA 689\/12-1"],"award-info":[{"award-number":["RA 689\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is characterized by the accumulation of \u03b2-amyloid peptide (A\u03b2). It affects cognition and leads to memory impairment. The mitochondrial translocator protein (TSPO) plays an essential role in maintaining mitochondrial homeostasis and has been implicated in several neuronal disorders or neuronal injuries. Ligands targeting the mitochondrial translocator protein (18\u2009kDa), promote neurosteroidogenesis and may be neuroprotective. To study whether the TSPO ligand XBD173 may exert early neuroprotective effects in AD pathology we investigated the impact of XBD173 on amyloid toxicity and neuroplasticity in mouse models of AD. We show that XBD173 (emapunil), via neurosteroid-mediated signaling and delta subunit-containing GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptors, prevents the neurotoxic effect of A\u03b2 on long-term potentiation (CA1-LTP) in the hippocampus and prevents the loss of spines. Chronic but not acute administration of XBD173 ameliorates spatial learning deficits in transgenic AD mice with arctic mutation (ArcA\u03b2). The heterozygous TSPO-knockout crossed with the transgenic arctic mutation model of AD mice (het TSPOKO X ArcA\u03b2) treated with XBD173 does not show this improvement in spatial learning suggesting TSPO is needed for procognitive effects of XBD173. The neuroprotective profile of XBD173 in AD pathology is further supported by a reduction in plaques and soluble A\u03b2 levels in the cortex, increased synthesis of neurosteroids, rescued spine density, reduction of complement protein C1q deposits, and reduced astrocytic phagocytosis of functional synapses both in the hippocampus and cortex. Our findings suggest that XBD173 may exert therapeutic effects via TSPO in a mouse model of AD.\n                  <\/jats:p>","DOI":"10.1038\/s41398-023-02630-z","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:03:30Z","timestamp":1698401010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18\u2009kDa translocator protein (TSPO) in a mouse model of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-7615","authenticated-orcid":false,"given":"Arpit Kumar","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Neum\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7054-9566","authenticated-orcid":false,"given":"Martin","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ballmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina Johanna","family":"Tartler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sanchez","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Liere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kreuzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2939-9062","authenticated-orcid":false,"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Rammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2630_CR1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan R, Reddy PH. Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J Alzheimer\u2019s Dis. 2017;57:975\u201399.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2630_CR2","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.neurobiolaging.2007.02.027","volume":"29","author":"L Tong","year":"2008","unstructured":"Tong L, Balazs R, Soiampornkul R, Thangnipon W, Cotman CW. Interleukin-1\u03b2 impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging. 2008;29:1380\u201393.","journal-title":"Neurobiol Aging"},{"key":"2630_CR3","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.bbadis.2014.08.001","volume":"1842","author":"SE Terrill-Usery","year":"2014","unstructured":"Terrill-Usery SE, Mohan MJ, Nichols MR. Amyloid-\u03b2 (1-42) protofibrils stimulate a quantum of secreted IL-1\u03b2 despite significant intracellular IL-1\u03b2 accumulation in microglia. Biochim Biophys Acta. 2014;1842:2276\u201385.","journal-title":"Biochim Biophys Acta"},{"key":"2630_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnagi.2013.00028","volume":"5","author":"KR Zahs","year":"2013","unstructured":"Zahs KR, Ashe KH. \u03b2-Amyloid oligomers in aging and Alzheimer\u2019s disease. Front Aging Neurosci. 2013;5:28.","journal-title":"Front Aging Neurosci"},{"key":"2630_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","volume":"44","author":"DM Walsh","year":"2004","unstructured":"Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease. Neuron. 2004;44:181\u201393.","journal-title":"Neuron."},{"key":"2630_CR6","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3390\/ijms19082415","volume":"19","author":"DM\u00c1 Villalobos Acosta","year":"2018","unstructured":"Villalobos Acosta DM\u00c1, Chimal Vega B, Correa Basurto J, Fragoso Morales LG, Rosales, Hern\u00e1ndez MC. Recent advances by in silico and in vitro studies of amyloid-\u03b2 1-42 fibril depicted a S-shape conformation. Int J Mol Sci. 2018;19:2415.","journal-title":"Int J Mol Sci"},{"key":"2630_CR7","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1073\/pnas.0901085106","volume":"106","author":"R Zhang","year":"2009","unstructured":"Zhang R, Hu X, Khant H, Ludtke SJ, Chiu W, Schmid MF, et al. Interprotofilament interactions between Alzheimer\u2019s A\u03b21\u201342 peptides in amyloid fibrils revealed by cryoEM. Proc Natl Acad Sci. 2009;106:4653\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"2630_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nbd.2015.10.019","volume":"85","author":"M Lei","year":"2016","unstructured":"Lei M, Xu H, Li Z, Wang Z, O\u2019Malley TT, Zhang D, et al. Soluble A\u03b2 oligomers impair hippocampal LTP by disrupting glutamatergic\/GABAergic balance. Neurobiol Dis. 2016;85:111\u201321.","journal-title":"Neurobiol Dis"},{"key":"2630_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnins.2019.00043","volume":"13","author":"J Liu","year":"2019","unstructured":"Liu J, Chang L, Song Y, Li H, Wu Y. The role of NMDA receptors in Alzheimer\u2019s disease. Front Neurosci. 2019;13:43.","journal-title":"Front Neurosci"},{"key":"2630_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L. Amyloid-\u03b2\u2013induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci. 2010;13:812\u20138.","journal-title":"Nat Neurosci"},{"key":"2630_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron. 2007;55:697\u2013711.","journal-title":"Neuron."},{"key":"2630_CR12","doi-asserted-by":"publisher","first-page":"e2259","DOI":"10.1212\/WNL.0000000000010612","volume":"95","author":"AD Lam","year":"2020","unstructured":"Lam AD, Sarkis RA, Pellerin KR, Jing J, Dworetzky BA, Hoch DB, et al. Association of epileptiform abnormalities and seizures in Alzheimer disease. Neurology. 2020;95:e2259\u201370.","journal-title":"Neurology."},{"key":"2630_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00702-019-02126-5","volume":"127","author":"P Missonnier","year":"2020","unstructured":"Missonnier P, Pr\u00e9vot A, Herrmann FR, Ventura J, Pad\u00e9e A, Merlo MCG. Disruption of gamma\u2013delta relationship related to working memory deficits in first-episode psychosis. J Neural Transm. 2020;127:103\u201315.","journal-title":"J Neural Transm"},{"key":"2630_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3389\/fnins.2020.00660","volume":"14","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhao M, Han Y, Zhang H. GABAergic inhibitory interneuron deficits in Alzheimer\u2019s disease: implications for treatment. Front Neurosci. 2020;14:660.","journal-title":"Front Neurosci"},{"key":"2630_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","volume":"37","author":"F Kamenetz","year":"2003","unstructured":"Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron. 2003;37:925\u201337.","journal-title":"Neuron."},{"key":"2630_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, et al. Translocator protein (18 kDa)(TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9:971\u201388.","journal-title":"Nat Rev Drug Discov"},{"key":"2630_CR17","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1021\/acschemneuro.2c00582","volume":"13","author":"F Corsi","year":"2022","unstructured":"Corsi F, Baglini E, Barresi E, Salerno S, Cerri C, Martini C, et al. Targeting TSPO reduces inflammation and apoptosis in an in vitro photoreceptor-like model of retinal degeneration. ACS Chem Neurosci. 2022;13:3188\u201397.","journal-title":"ACS Chem Neurosci"},{"key":"2630_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pharmthera.2007.03.008","volume":"116","author":"SS Smith","year":"2007","unstructured":"Smith SS, Shen H, Gong QH, Zhou X. Neurosteroid regulation of GABAA receptors: focus on the \u03b14 and \u03b4 subunits. Pharmacol Ther. 2007;116:58\u201376.","journal-title":"Pharmacol Ther"},{"key":"2630_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/cells9040870","volume":"9","author":"J Dimitrova-Shumkovska","year":"2020","unstructured":"Dimitrova-Shumkovska J, Krstanoski L, Veenman L. Diagnostic and therapeutic potential of TSPO studies regarding neurodegenerative diseases, psychiatric disorders, alcohol use disorders, traumatic brain injury, and stroke: an update. Cells. 2020;9:870.","journal-title":"Cells."},{"key":"2630_CR20","doi-asserted-by":"crossref","unstructured":"Ceyz\u00e9riat K, Meyer L, Bouteldja F, Tsartsalis S, Amoss\u00e9 Q, Middleton RJ, et al. Knockout of TSPO delays and reduces amyloid, Tau, astrocytosis and behavioral dysfunctions in Alzheimer\u2019s disease. bioRxiv. 2022;2003\u201322.","DOI":"10.1101\/2022.03.26.485919"},{"key":"2630_CR21","doi-asserted-by":"publisher","first-page":"e2209177120","DOI":"10.1073\/pnas.2209177120","volume":"120","author":"LH Fairley","year":"2023","unstructured":"Fairley LH, Lai KO, Wong JH, Chong WJ, Vincent AS, D\u2019Agostino G, et al. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer\u2019s disease. Proc Natl Acad Sci. 2023;120:e2209177120.","journal-title":"Proc Natl Acad Sci"},{"key":"2630_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neurobiolaging.2021.06.020","volume":"106","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang H, Gao F, Yang J, Xu Y, Fu Y, et al. TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis. Neurobiol Aging. 2021;106:292\u2013303.","journal-title":"Neurobiol Aging"},{"key":"2630_CR23","doi-asserted-by":"publisher","first-page":"8891","DOI":"10.1523\/JNEUROSCI.1350-13.2013","volume":"33","author":"AM Barron","year":"2013","unstructured":"Barron AM, Garcia-Segura LM, Caruso D, Jayaraman A, Lee J-W, Melcangi RC, et al. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2013;33:8891\u20137.","journal-title":"J Neurosci"},{"key":"2630_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neulet.2018.06.029","volume":"683","author":"A Christensen","year":"2018","unstructured":"Christensen A, Pike CJ. TSPO ligand PK11195 improves Alzheimer-related outcomes in aged female 3xTg-AD mice. Neurosci Lett. 2018;683:7\u201312.","journal-title":"Neurosci Lett"},{"key":"2630_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.brainresbull.2016.02.001","volume":"121","author":"L Ma","year":"2016","unstructured":"Ma L, Zhang H, Liu N, Wang P, Guo W, Fu Q, et al. TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration. Brain Res Bull. 2016;121:192\u2013200.","journal-title":"Brain Res Bull"},{"key":"2630_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41593-022-01013-9","volume":"25","author":"Y Shi","year":"2022","unstructured":"Shi Y, Cui M, Ochs K, Brendel M, Str\u00fcbing FL, Briel N, et al. Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO). Nat Neurosci. 2022;25:317\u201329.","journal-title":"Nat Neurosci"},{"key":"2630_CR27","doi-asserted-by":"publisher","first-page":"750554","DOI":"10.3389\/fphar.2022.750554","volume":"13","author":"RM Hines","year":"2022","unstructured":"Hines RM, Aquino EA, Khumnark MI, D\u00e1vila MP, Hines DJ. Comparative assessment of TSPO modulators on electroencephalogram activity and exploratory behavior. Front Pharmacol. 2022;13:750554.","journal-title":"Front Pharmacol"},{"key":"2630_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.1175055","volume":"325","author":"R Rupprecht","year":"2009","unstructured":"Rupprecht R, Rammes G, Eser D, Baghai TC, Sch\u00fcle C, Nothdurfter C, et al. Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science. 2009;325:490\u20133.","journal-title":"Science"},{"key":"2630_CR29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.neurobiolaging.2006.06.019","volume":"28","author":"M Knobloch","year":"2007","unstructured":"Knobloch M, Konietzko U, Krebs DC, Nitsch RM. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging. 2007;28:1297\u2013306.","journal-title":"Neurobiol Aging"},{"key":"2630_CR30","doi-asserted-by":"publisher","first-page":"27444","DOI":"10.1074\/jbc.M114.578286","volume":"289","author":"LN Tu","year":"2014","unstructured":"Tu LN, Morohaku K, Manna PR, Pelton SH, Butler WR, Stocco DM, et al. Peripheral benzodiazepine receptor\/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis*\u2666. J Biol Chem. 2014;289:27444\u201354.","journal-title":"J Biol Chem"},{"key":"2630_CR31","doi-asserted-by":"publisher","first-page":"12905","DOI":"10.1073\/pnas.96.22.12905","volume":"96","author":"RM Mihalek","year":"1999","unstructured":"Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi Z-P, et al. Attenuated sensitivity to neuroactive steroids in \u03b3-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci. 1999;96:12905\u201310.","journal-title":"Proc Natl Acad Sci"},{"key":"2630_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuropharm.2018.07.021","volume":"140","author":"G Rammes","year":"2018","unstructured":"Rammes G, Seeser F, Mattusch K, Zhu K, Haas L, Kummer M, et al. The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (A\u03b2) species on long-term potentiation (LTP). Neuropharmacology. 2018;140:184\u201392.","journal-title":"Neuropharmacology."},{"key":"2630_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fnbeh.2012.00087","volume":"6","author":"KR Kleinknecht","year":"2012","unstructured":"Kleinknecht KR, Bedenk BT, Kaltwasser SF, Gr\u00fcnecker B, Yen Y-C, Czisch M, et al. Hippocampus-dependent place learning enables spatial flexibility in C57BL6\/N mice. Front Behav Neurosci. 2012;6:87.","journal-title":"Front Behav Neurosci"},{"key":"2630_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1124\/mol.110.069542","volume":"80","author":"EV Morlock","year":"2011","unstructured":"Morlock EV, Czajkowski C. Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding. Mol Pharmacol. 2011;80:14\u201322.","journal-title":"Mol Pharmacol"},{"key":"2630_CR35","doi-asserted-by":"publisher","first-page":"101687","DOI":"10.1016\/j.xpro.2022.101687","volume":"3","author":"AK Pradhan","year":"2022","unstructured":"Pradhan AK, Shi Q, Tartler KJ, Rammes G. Quantification of astrocytic synaptic pruning in mouse hippocampal slices in response to ex vivo A\u03b2 treatment via colocalization analysis with C1q. STAR Protoc. 2022;3:101687.","journal-title":"STAR Protoc"},{"key":"2630_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"2630_CR37","doi-asserted-by":"publisher","first-page":"10998","DOI":"10.1523\/JNEUROSCI.3874-16.2017","volume":"37","author":"X Zhu","year":"2017","unstructured":"Zhu X, Fr\u00e9chou M, Liere P, Zhang S, Pianos A, Fernandez N, et al. A role of endogenous progesterone in stroke cerebroprotection revealed by the neural-specific deletion of its intracellular receptors. J Neurosci. 2017;37:10998\u20131020.","journal-title":"J Neurosci"},{"key":"2630_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1101\/lm.035972.114","volume":"21","author":"A Villers","year":"2014","unstructured":"Villers A, Giese KP, Ris L. Long-term potentiation can be induced in the CA1 region of hippocampus in the absence of \u03b1CaMKII T286-autophosphorylation. Learn Mem. 2014;21:616\u201326.","journal-title":"Learn Mem"},{"key":"2630_CR39","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/00000542-200106000-00021","volume":"94","author":"W Simon","year":"2001","unstructured":"Simon W, Hapfelmeier G, Kochs E, Zieglg\u00e4nsberger W, Rammes G. Isoflurane blocks synaptic plasticity in the mouse hippocampus. J Am Soc Anesthesiol. 2001;94:1058\u201365.","journal-title":"J Am Soc Anesthesiol"},{"key":"2630_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mce.2015.03.014","volume":"408","author":"V Papadopoulos","year":"2015","unstructured":"Papadopoulos V, Aghazadeh Y, Fan J, Campioli E, Zirkin B, Midzak A. Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis. Mol Cell Endocrinol. 2015;408:90\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"2630_CR41","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1038\/s41380-022-01561-3","volume":"27","author":"R Rupprecht","year":"2022","unstructured":"Rupprecht R, Wetzel CH, Dorostkar M, Herms J, Albert NL, Schwarzbach J, et al. Translocator protein (18 kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders? Mol Psychiatry. 2022;27:2918\u201326.","journal-title":"Mol Psychiatry"},{"key":"2630_CR42","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3233\/JAD-190127","volume":"72","author":"I Lejri","year":"2019","unstructured":"Lejri I, Grimm A, Hall\u00e9 F, Abarghaz M, Klein C, Maitre M, et al. TSPO ligands boost mitochondrial function and pregnenolone synthesis. J Alzheimer\u2019s Dis. 2019;72:1045\u201358.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2630_CR43","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/ijms17071028","volume":"17","author":"E Da Pozzo","year":"2016","unstructured":"Da Pozzo E, Giacomelli C, Costa B, Cavallini C, Taliani S, Barresi E, et al. TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being. Int J Mol Sci. 2016;17:1028.","journal-title":"Int J Mol Sci"},{"key":"2630_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","volume":"44","author":"RC Malenka","year":"2004","unstructured":"Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44:5\u201321.","journal-title":"Neuron."},{"key":"2630_CR45","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.neurobiolaging.2006.06.019","volume":"28","author":"M Knobloch","year":"2007","unstructured":"Knobloch M, Konietzko U, Krebs DC, Nitsch RM. Intracellular A\u03b2 and cognitive deficits precede \u03b2-amyloid deposition in transgenic arcA\u03b2 mice. Neurobiol Aging. 2007;28:1297\u2013306.","journal-title":"Neurobiol Aging"},{"key":"2630_CR46","doi-asserted-by":"publisher","first-page":"815347.","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y. Microglia polarization from m1 to m2 in neurodegenerative diseases. Front Aging Neurosci. 2022;14:815347.","journal-title":"Front Aging Neurosci"},{"key":"2630_CR47","doi-asserted-by":"publisher","first-page":"772717.","DOI":"10.3389\/fnagi.2021.772717","volume":"13","author":"Q Wang","year":"2021","unstructured":"Wang Q, Yao H, Liu W, Ya B, Cheng H, Xing Z, et al. Microglia polarization in Alzheimer\u2019s disease: mechanisms and a potential therapeutic target. Front Aging Neurosci. 2021;13:772717.","journal-title":"Front Aging Neurosci"},{"key":"2630_CR48","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1136\/annrheumdis-2018-213648","volume":"77","author":"S Soldano","year":"2018","unstructured":"Soldano S, Trombetta AC, Contini P, Tomatis V, Ruaro B, Brizzolara R, et al. Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis. Ann Rheum Dis. 2018;77:1842\u20135.","journal-title":"Ann Rheum Dis"},{"key":"2630_CR49","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217:459\u201372.","journal-title":"J Cell Biol"},{"key":"2630_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/acel.12522","volume":"16","author":"E Martin","year":"2017","unstructured":"Martin E, Boucher C, Fontaine B, Delarasse C. Distinct inflammatory phenotypes of microglia and monocyte\u2010derived macrophages in Alzheimer\u2019s disease models: effects of aging and amyloid pathology. Aging Cell. 2017;16:27\u201338.","journal-title":"Aging Cell"},{"key":"2630_CR51","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.bbadis.2016.07.007","volume":"1862","author":"W Kamphuis","year":"2016","unstructured":"Kamphuis W, Kooijman L, Schetters S, Orre M, Hol EM. Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer\u2019s disease. Biochim Biophys Acta. 2016;1862:1847\u201360.","journal-title":"Biochim Biophys Acta"},{"key":"2630_CR52","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","volume":"2","author":"B Dejanovic","year":"2022","unstructured":"Dejanovic B, Wu T, Tsai M-C, Graykowski D, Gandham VD, Rose CM, et al. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer\u2019s disease mouse models. Nat Aging. 2022;2:837\u201350.","journal-title":"Nat Aging"},{"key":"2630_CR53","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","volume":"31","author":"S Li","year":"2011","unstructured":"Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, Selkoe DJ. Soluble A\u03b2 oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J Neurosci. 2011;31:6627\u201338.","journal-title":"J Neurosci"},{"key":"2630_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnsyn.2020.00031","volume":"12","author":"E Pchitskaya","year":"2020","unstructured":"Pchitskaya E, Bezprozvanny I. Dendritic spines shape analysis\u2014Classification or clusterization? Perspective. Front Synaptic Neurosci. 2020;12:31.","journal-title":"Front Synaptic Neurosci"},{"key":"2630_CR55","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1042\/BCJ20170648","volume":"474","author":"DR Owen","year":"2017","unstructured":"Owen DR, Fan J, Campioli E, Venugopal S, Midzak A, Daly E, et al. TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis. Biochem J. 2017;474:3985\u201399.","journal-title":"Biochem J"},{"key":"2630_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fendo.2011.00044","volume":"2","author":"M Wang","year":"2011","unstructured":"Wang M. Neurosteroids and GABA-A receptor function. Front Endocrinol (Lausanne). 2011;2:44.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2630_CR57","first-page":"148","volume":"120","author":"H Saleh","year":"2019","unstructured":"Saleh H, Sadeghi L. Investigation of THDOC effects on pathophysiological signs of Alzheimer\u2019s disease as an endogenous neurosteroid: inhibition of acetylcholinesterase and plaque deposition. Bratisl Lek Listy. 2019;120:148\u201354.","journal-title":"Bratisl Lek Listy"},{"key":"2630_CR58","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, St\u00f6ffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology. 2007;53:699\u2013723.","journal-title":"Neuropharmacology."},{"key":"2630_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","volume":"73","author":"SG Brickley","year":"2012","unstructured":"Brickley SG, Mody I. Extrasynaptic GABAA receptors: their function in the CNS and implications for disease. Neuron. 2012;73:23\u201334.","journal-title":"Neuron."},{"key":"2630_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.tins.2010.10.005","volume":"34","author":"M Capogna","year":"2011","unstructured":"Capogna M, Pearce RA. GABAA, slow: causes and consequences. Trends Neurosci. 2011;34:101\u201312.","journal-title":"Trends Neurosci"},{"key":"2630_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06004-8","volume":"9","author":"JM Schulz","year":"2018","unstructured":"Schulz JM, Knoflach F, Hernandez M-C, Bischofberger J. Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear \u03b15-GABAA receptors. Nat Commun. 2018;9:3576.","journal-title":"Nat Commun"},{"key":"2630_CR62","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1152\/jn.01022.2002","volume":"90","author":"I Spigelman","year":"2003","unstructured":"Spigelman I, Li Z, Liang J, Cagetti E, Samzadeh S, Mihalek RM, et al. Reduced inhibition and sensitivity to neurosteroids in hippocampus of mice lacking the GABAA receptor \u03b4 subunit. J Neurophysiol. 2003;90:903\u201310.","journal-title":"J Neurophysiol"},{"key":"2630_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2010.06.013","volume":"327","author":"A Batarseh","year":"2010","unstructured":"Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol. 2010;327:1\u201312.","journal-title":"Mol Cell Endocrinol"},{"key":"2630_CR64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00259-020-05166-2","volume":"49","author":"E Nutma","year":"2021","unstructured":"Nutma E, Ceyz\u00e9riat K, Amor S, Tsartsalis S, Millet P, Owen DR, et al. Cellular sources of TSPO expression in healthy and diseased brain. Eur J Nucl Med Mol Imaging. 2021;49:146\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2630_CR65","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1016\/j.bbadis.2017.09.007","volume":"1863","author":"G Leva","year":"2017","unstructured":"Leva G, Klein C, Benyounes J, Hall\u00e9 F, Bihel F, Collongues N, et al. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL\/J mouse model of multiple sclerosis. Biochim Biophys Acta. 2017;1863:3016\u201327.","journal-title":"Biochim Biophys Acta"},{"key":"2630_CR66","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1021\/acschemneuro.6b00149","volume":"7","author":"B Costa","year":"2016","unstructured":"Costa B, Da Pozzo E, Cavallini C, Taliani S, Da Settimo F, Martini C. Long residence time at the neurosteroidogenic 18 kDa translocator protein characterizes the anxiolytic ligand XBD173. ACS Chem Neurosci. 2016;7:1041\u20136.","journal-title":"ACS Chem Neurosci"},{"key":"2630_CR67","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-981-13-9913-8_11","volume":"1175","author":"A Verkhratsky","year":"2019","unstructured":"Verkhratsky A, Parpura V, Rodriguez-Arellano JJ, Zorec R. Astroglia in Alzheimer\u2019s disease. Adv Exp Med Biol. 2019;1175:273\u2013324.","journal-title":"Adv Exp Med Biol"},{"key":"2630_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40937-z","volume":"14","author":"E Nutma","year":"2023","unstructured":"Nutma E, Fancy N, Weinert M, Tsartsalis S, Marzin MC, Muirhead RCJ, et al. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases. Nat Commun. 2023;14:5247.","journal-title":"Nat Commun"},{"key":"2630_CR69","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/glia.24052","volume":"69","author":"E Nutma","year":"2021","unstructured":"Nutma E, Gebro E, Marzin MC, van der Valk P, Matthews PM, Owen DR, et al. Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain. Glia. 2021;69:2447\u201358.","journal-title":"Glia."},{"key":"2630_CR70","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s12035-020-02136-5","volume":"58","author":"AM Barron","year":"2021","unstructured":"Barron AM, Higuchi M, Hattori S, Kito S, Suhara T, Ji B. Regulation of anxiety and depression by mitochondrial translocator protein-mediated steroidogenesis: the role of neurons. Mol Neurobiol. 2021;58:550\u201363.","journal-title":"Mol Neurobiol"},{"key":"2630_CR71","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41380-020-0745-1","volume":"26","author":"T Notter","year":"2021","unstructured":"Notter T, Schalbetter SM, Clifton NE, Mattei D, Richetto J, Thomas K, et al. Neuronal activity increases translocator protein (TSPO) levels. Mol Psychiatry [Internet]. 2021;26:2025\u201337. https:\/\/doi.org\/10.1038\/s41380-020-0745-1.","journal-title":"Mol Psychiatry [Internet]"},{"key":"2630_CR72","doi-asserted-by":"publisher","first-page":"899251","DOI":"10.3389\/fncel.2022.899251","volume":"16","author":"LA Hulshof","year":"2022","unstructured":"Hulshof LA, Van Nuijs D, Hol EM, Middeldorp J. The role of astrocytes in synapse loss in Alzheimer\u2019s disease: a systematic review. Front Cell Neurosci. 2022;16:899251.","journal-title":"Front Cell Neurosci"},{"key":"2630_CR73","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"2630_CR74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2019.00063","volume":"13","author":"CM Henstridge","year":"2019","unstructured":"Henstridge CM, Tzioras M, Paolicelli RC. Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration. Front Cell Neurosci. 2019;13:63.","journal-title":"Front Cell Neurosci"},{"key":"2630_CR75","doi-asserted-by":"publisher","first-page":"13647","DOI":"10.3390\/ijms222413647","volume":"22","author":"A Shah","year":"2021","unstructured":"Shah A, Kishore U, Shastri A. Complement system in Alzheimer\u2019s disease. Int J Mol Sci. 2021;22:13647.","journal-title":"Int J Mol Sci"},{"key":"2630_CR76","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/ITT.S305420","volume":"10","author":"A Gomez-Arboledas","year":"2021","unstructured":"Gomez-Arboledas A, Acharya MM, Tenner AJ. The role of complement in synaptic pruning and neurodegeneration. ImmunoTargets Ther. 2021;10:373.","journal-title":"ImmunoTargets Ther"},{"key":"2630_CR77","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1523\/JNEUROSCI.3850-15.2016","volume":"36","author":"T Iram","year":"2016","unstructured":"Iram T, Ramirez-Ortiz Z, Byrne MH, Coleman UA, Kingery ND, Means TK, et al. Megf10 is a receptor for C1Q that mediates clearance of apoptotic cells by astrocytes. J Neurosci. 2016;36:5185\u201392.","journal-title":"J Neurosci"},{"key":"2630_CR78","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/jnr.490390412","volume":"39","author":"S Webster","year":"1994","unstructured":"Webster S, O\u2019barr S, Rogers J. Enhanced aggregation and \u03b2 structure of amyloid \u03b2 peptide after coincubation with C1q. J Neurosci Res. 1994;39:448\u201356.","journal-title":"J Neurosci Res"},{"key":"2630_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0165-5728(03)00040-7","volume":"137","author":"M Sarvari","year":"2003","unstructured":"Sarvari M, Vago I, Weber CS, Nagy J, Gal P, Mak M, et al. Inhibition of C1q-\u03b2-amyloid binding protects hippocampal cells against complement mediated toxicity. J Neuroimmunol. 2003;137:12\u20138.","journal-title":"J Neuroimmunol"},{"key":"2630_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-022-01404-w","volume":"10","author":"SM Carpanini","year":"2022","unstructured":"Carpanini SM, Torvell M, Bevan RJ, Byrne RAJ, Daskoulidou N, Saito T, et al. Terminal complement pathway activation drives synaptic loss in Alzheimer\u2019s disease models. Acta Neuropathol Commun. 2022;10:1\u201316.","journal-title":"Acta Neuropathol Commun"},{"key":"2630_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-021-02122-1","volume":"18","author":"LH Fairley","year":"2021","unstructured":"Fairley LH, Sahara N, Aoki I, Ji B, Suhara T, Higuchi M, et al. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy. J Neuroinflammation. 2021;18:1\u201313.","journal-title":"J Neuroinflammation"},{"key":"2630_CR82","doi-asserted-by":"crossref","unstructured":"Rupprecht C, Rupprecht R, Rammes G. C1q, a small molecule with high impact on brain development: putative role for aging processes and the occurrence of Alzheimer\u2019s disease. European Archives of Psychiatry and Clinical Neuroscience. Springer; 2021. p. 809\u201312.","DOI":"10.1007\/s00406-021-01273-9"},{"key":"2630_CR83","doi-asserted-by":"publisher","first-page":"11830","DOI":"10.1073\/pnas.192203399","volume":"99","author":"LV Johnson","year":"2002","unstructured":"Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer\u2019s A\u03b2-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci. 2002;99:11830\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"2630_CR84","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4049\/jimmunol.1901068","volume":"204","author":"AJ Tenner","year":"2020","unstructured":"Tenner AJ. Complement-mediated events in Alzheimer\u2019s disease: mechanisms and potential therapeutic targets. J Immunol. 2020;204:306\u201315.","journal-title":"J Immunol"},{"key":"2630_CR85","unstructured":"Kennedy A. mouse profile. 2020 Jul 1 [cited 2023 Feb 16]; Available from: https:\/\/zenodo.org\/record\/3925921"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02630-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02630-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02630-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:03:53Z","timestamp":1698401033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02630-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2630"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02630-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.23.529740","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}